📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Galactose-modified duocarmycin prodrugs as senolytics. (2020)

First Author: Guerrero A

Attributed to: Molecular and Cellular Mechanisms Underlying Pituitary Tumours funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/acel.13133

PubMed Identifier: 32175667

Publication URI: http://europepmc.org/abstract/MED/32175667

Type: Journal Article/Review

Volume: 19

Parent Publication: Aging cell

Issue: 4

ISSN: 1474-9718